New! Sign up for our free email newsletter.
Science News
from research organizations

Novel Anti-inflammatory Molecules Of Microbial Origin

Date:
September 8, 2009
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
By studying the mycobacteria that cause tuberculosis, molecules with anti-inflammatory properties have been identified by researchers. These molecules, as well as several new analogs, have now been synthesized. In a new study, researchers report the anti-inflammatory activity of these molecules.
Share:
FULL STORY

By studying the mycobacteria that cause tuberculosis, molecules with anti-inflammatory properties have been identified by the team led by Valérie Quesniaux in the Laboratoire Immunologie et Embryologie Moléculaires, working in collaboration with the Institut de Chimie Organique et Analytique (both based in the University of Orléans/CNRS). These molecules, as well as several new analogs, have been synthesized. Their anti-inflammatory activity has been confirmed, improved and demonstrated in the mouse, as reported in The Journal of Biological Chemistry on August 28, 2009.

The mycobacteria that cause tuberculosis (Mycobacterium tuberculosis) can remain silent for many years in man, thus eluding surveillance by the immune system. In 90% of individuals, the infection is controlled but not eradicated, and the mycobacterium can sometimes survive for several decades. Mycobacterium tuberculosis produces several complex proteins and glycolipids (a combination of sugars and lipids) that are capable of modulating the immune response.

Valérie Quesniaux's team has focused on the interactions between the mycobacterium and its host at the molecular scale, and on the resulting immune mechanisms. On the cell wall of the mycobacteria, the scientists identified low molecular mass glycolipids with very interesting anti-inflammatory properties, the PIM (Phosphatidyl Inositol Mannosides). They synthesized these PIM and reproduced their anti-inflammatory properties.

The team then turned to the synthesis of novel, analog molecules, thus considerably simplifying their synthesis. And indeed, the first example of this new family proved to be even more active than the natural or synthetic molecules tested hitherto. During their study, the researchers demonstrated the enhanced anti-inflammatory activity of these novel PIM molecules both in vitro and in an in vivo model of pulmonary inflammation.

Two patents have been filed in the context of this research. The use of such immunomodulating molecules of microbial origin for therapeutic purposes is seeing considerable growth. These new molecules could be used in the treatment of severe, chronic, inflammatory diseases such as rheumatoid arthritis, Crohn's disease or psoriasis.


Story Source:

Materials provided by CNRS (Délégation Paris Michel-Ange). Note: Content may be edited for style and length.


Journal Reference:

  1. Emilie Doz, Stéphanie Rose, Nathalie Court, Sophie Front, Virginie Vasseur, Sabine Charron, Martine Gilleron, Germain Puzo, Isabelle Fremaux, Yves Delneste, François Erard, Bernhard Ryffel, Olivier R. Martin and Valerie F. J. Quesniaux. Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression. Journal of Biological Chemistry, 2009; 284 (35): 23187 DOI: 10.1074/jbc.M109.037846

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Novel Anti-inflammatory Molecules Of Microbial Origin." ScienceDaily. ScienceDaily, 8 September 2009. <www.sciencedaily.com/releases/2009/09/090902122525.htm>.
CNRS (Délégation Paris Michel-Ange). (2009, September 8). Novel Anti-inflammatory Molecules Of Microbial Origin. ScienceDaily. Retrieved March 29, 2024 from www.sciencedaily.com/releases/2009/09/090902122525.htm
CNRS (Délégation Paris Michel-Ange). "Novel Anti-inflammatory Molecules Of Microbial Origin." ScienceDaily. www.sciencedaily.com/releases/2009/09/090902122525.htm (accessed March 29, 2024).

Explore More

from ScienceDaily

RELATED STORIES